SCHEMBL26389177

SCHEMBL26389177

COc1nc(-c2cccc(OCC(=O)NC(C)C)c2)nc2ccccc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 5/20 0.63
▸ CYP3A4 P08684 4/20 0.63
▸ NR1I3 Q14994 2/20 0.63
▸ CYP2C9 P11712 2/20 0.63
▸ VDR P11473 1/20 0.63
▸ CYP2B6 P20813 1/20 0.63
▸ AHR P35869 1/20 0.63
▸ ROCK2 O75116 6/20 0.62
▸ CLK4 Q9HAZ1 3/20 0.62
▸ ROCK1 Q13464 3/20 0.62
▸ CLK2 P49760 1/20 0.62
▸ BLK P51451 1/20 0.62
▸ CSNK2A1 P68400 1/20 0.62
▸ STK3 Q13188 1/20 0.62
▸ DYRK1A Q13627 1/20 0.62
▸ AURKB Q96GD4 1/20 0.62
▸ STK17A Q9UEE5 1/20 0.62
▸ MAPT P10636 3/20 0.57
▸ ATM Q13315 1/20 0.57
▸ POLB P06746 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28777039 0.89 ROCK2 (0.63) CYP1A2CYP3A4NR1I3CYP2C9VDR
SCHEMBL30634518 0.88 ROCK2 (0.62) CYP1A2CYP3A4NR1I3CYP2C9VDR
SCHEMBL26118180 0.88 ROCK2 (0.62) CYP1A2CYP3A4NR1I3CYP2C9VDR
SCHEMBL23587500 0.87 ROCK2 (0.69) CYP1A2CYP3A4CYP2C9ROCK2CLK4
SCHEMBL882944 0.85 ROCK2 (0.77) CYP1A2CYP3A4ROCK2CLK4ROCK1
SCHEMBL27248939 0.85 ROCK2 (0.74) CYP1A2CYP3A4ROCK2CLK4ROCK1
SCHEMBL15638092 0.79 ROCK2 (0.54) ROCK2CLK4ROCK1CLK2BLK
SCHEMBL26120225 0.79 CDK4 (0.56) CYP1A2ROCK2CLK4ROCK1CLK2
SCHEMBL27066406 0.79 ROCK2 (0.70) ROCK2CLK4ROCK1CLK2BLK
SCHEMBL10218168 0.78 ROCK2 (0.71) CYP1A2CYP3A4ROCK2CLK4ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023187697-A1 PROCESS FOR THE PREPARATION OF BELUMOSUDIL MESYLATE AND ITS CRYSTALLINE FORM GLENMARK LIFE SCIENCES LIMITED (IN) 2023-10-05 — — WO disclosed
Send feedback